Friebel Ekaterina, Kapolou Konstantina, Unger Susanne, Núñez Nicolás Gonzalo, Utz Sebastian, Rushing Elisabeth Jane, Regli Luca, Weller Michael, Greter Melanie, Tugues Sonia, Neidert Marian Christoph, Becher Burkhard
Institute of Experimental Immunology, University of Zurich, Zurich 8057, Switzerland.
Laboratory of Molecular Neuro-Oncology, Department of Neurology, Clinical Neuroscience Center, University Hospital Zurich and University of Zurich, Zurich 8091, Switzerland.
Cell. 2020 Jun 25;181(7):1626-1642.e20. doi: 10.1016/j.cell.2020.04.055. Epub 2020 May 28.
Brain malignancies can either originate from within the CNS (gliomas) or invade from other locations in the body (metastases). A highly immunosuppressive tumor microenvironment (TME) influences brain tumor outgrowth. Whether the TME is predominantly shaped by the CNS micromilieu or by the malignancy itself is unknown, as is the diversity, origin, and function of CNS tumor-associated macrophages (TAMs). Here, we have mapped the leukocyte landscape of brain tumors using high-dimensional single-cell profiling (CyTOF). The heterogeneous composition of tissue-resident and invading immune cells within the TME alone permitted a clear distinction between gliomas and brain metastases (BrM). The glioma TME presented predominantly with tissue-resident, reactive microglia, whereas tissue-invading leukocytes accumulated in BrM. Tissue-invading TAMs showed a distinctive signature trajectory, revealing tumor-driven instruction along with contrasting lymphocyte activation and exhaustion. Defining the specific immunological signature of brain tumors can facilitate the rational design of targeted immunotherapy strategies.
脑恶性肿瘤既可以起源于中枢神经系统(CNS)内部(胶质瘤),也可以从身体其他部位侵袭而来(转移瘤)。高度免疫抑制的肿瘤微环境(TME)会影响脑肿瘤的生长。目前尚不清楚TME主要是由CNS微环境还是恶性肿瘤本身塑造的,同样未知的还有CNS肿瘤相关巨噬细胞(TAM)的多样性、起源和功能。在这里,我们使用高维单细胞分析(质谱流式细胞术)绘制了脑肿瘤的白细胞图谱。仅TME内组织驻留和浸润免疫细胞的异质组成就使得胶质瘤和脑转移瘤(BrM)之间有了明确区分。胶质瘤TME主要表现为组织驻留的反应性小胶质细胞,而组织浸润性白细胞则在BrM中积聚。组织浸润性TAM显示出独特的特征轨迹,揭示了肿瘤驱动的指令以及淋巴细胞激活和耗竭的对比情况。确定脑肿瘤的特定免疫特征有助于合理设计靶向免疫治疗策略。